Deciding About Emergency Surgery in a Patient With Decompensated Cirrhosis

Framing. This is a decision about goals and values, not just a probability calculation. The patient has a perforated viscus, which without source control is almost uniformly fatal; with surgery he faces high perioperative mortality driven by decompensated cirrhosis, shock, and sepsis. The honest framing is: surgery offers the only chance at source control but carries substantial risk of death or prolonged ICU dependence; nonoperative management is a comfort-focused or bridge strategy with very low likelihood of survival in this setting.

What to establish first.

• Decision-making capacity: he is confused (asterixis, possible hepatic encephalopathy) and may lack capacity; identify the health care proxy and clarify prior expressed wishes.
• Reversibility: treat precipitants of decompensation - infection, GI bleed, hypovolemia - and reassess. Some of the apparent futility is modifiable.
• Prognosis data: Child-Pugh C and elevated MELD carry very high perioperative mortality for emergency abdominal surgery; this should inform, not dictate, the conversation.

Options to present.

1. Emergency laparotomy with source control, accepting high risk, with a plan for postoperative ICU care and clear triggers for reassessment if he deteriorates.
2. Nonoperative management with antibiotics, drainage if feasible (e.g., percutaneous), and comfort-focused care.
3. Time-limited trial of maximal support with a defined reassessment point.

The recommendation should be explicit: if the patient's values favor a chance at survival, operate; if they favor comfort and avoidance of prolonged ICU dependence, focus on palliation. Either way, involve palliative care early.

Hemodynamics and volume.

• Cirrhotic patients are typically vasodilated with a low effective circulating volume; they tolerate hypotension poorly and are prone to renal failure. Maintain perfusion with careful volume and vasopressors, avoiding both under-resuscitation and over-resuscitation (which worsens ascites and pulmonary edema).
• Avoid nephrotoxins; avoid NSAIDs and aminoglycosides.

Coagulopathy.

• INR 1.9 and platelets 62,000 reflect rebalanced hemostasis, not simply a bleeding diathesis; do not transfuse to correct numbers reflexively. Use viscoelastic testing if available and transfuse for bleeding or procedural need.
• Anticipate fibrinolysis and thrombocytopenia; have blood products available.

Encephalopathy.

• Lactulose and rifaximin; avoid sedatives that worsen encephalopathy; treat precipitants (infection, GI bleed, electrolyte disturbance).

Ascites and renal function.

• Hold diuretics perioperatively; monitor creatinine closely; recognize hepatorenal syndrome and consider terlipressin or albumin per protocol if it develops.
• Consider draining tense ascites to improve respiratory mechanics and abdominal wall closure.

Infection.

• Ascitic fluid is at risk for spontaneous bacterial peritonitis; send fluid for cell count and culture, and treat empirically.
• Broad-spectrum antibiotics with source control.

Nutrition and glucose.

• Avoid prolonged fasting; cirrhotic patients are catabolic. Monitor glucose closely.

Postoperative.

• Early ICU involvement, low threshold for re-exploration, and clear documentation of goals of care and triggers for re-discussion with the family.

Differential for oliguria and rising creatinine in a cirrhotic postoperative patient.

1. Hepatorenal syndrome (HRS-AKI) - functional renal failure from splanchnic vasodilation and renal vasoconstriction; diagnosis of exclusion.
2. Prerenal azotemia from hypovolemia, bleeding, or over-diuresis.
3. Acute tubular necrosis from hypotension, nephrotoxins, or sepsis.
4. Abdominal compartment syndrome - tense ascites plus postoperative edema can raise intra-abdominal pressure; check bladder pressure.
5. Sepsis - worsening intra-abdominal source.
6. Urinary obstruction - check the catheter.

Management.

• Assess volume status: review intake/output, weights, and dynamic measures; give a cautious albumin challenge if hypovolemic. Avoid aggressive crystalloid, which worsens ascites and edema.
• Rule out obstruction and check bladder pressure. If elevated, treat IAH and consider paracentesis.
• Hold diuretics and nephrotoxins.
• If HRS is likely after excluding other causes, start albumin plus a vasoconstrictor (terlipressin or norepinephrine per protocol) and involve hepatology for transplant evaluation.
• Treat infection aggressively; SBP can precipitate HRS.
• Consider renal replacement therapy if uremia, hyperkalemia, or volume overload is refractory, recognizing that this may be a bridge to transplant or a marker of futility depending on goals.
• Revisit goals of care with the family - the development of HRS in a Child-Pugh C postoperative patient is a major prognostic event and should trigger a documented discussion.